Daiichi Sankyo
Morgan Bowling, PharmD, currently serves as the Manager of Global Oncology Medical Affairs - Scientific Engagement at Daiichi Sankyo, Inc., a position held since July 2021. In this role, Morgan oversees the development of insights reports, contributes to KEE Engagement metrics, and leads communications for the International Working Group Ad Board. Previous positions within Daiichi Sankyo included various fellowships focusing on MSL Excellence, Patient Advocacy, and Evidence Generation & Strategy, where significant contributions were made in training program development, stakeholder engagement, and clinical strategy alignment. Prior experience includes a Clinical Development Intern role at BioCryst Pharmaceuticals, where Morgan improved training documentation systems and standardized processes for FDA audit preparation. Morgan earned a Doctor of Pharmacy degree from the UNC Eshelman School of Pharmacy and a Bachelor of Arts in Biology from the University of North Carolina at Chapel Hill.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.